Compounds and methods for the treatment of acute myelogenous leukemia
Abstract:
The present disclosure relates to compounds and methods for treating cancer, the methods comprising administering to the subject a compound of formula (1). In some embodiments, the disclosure provides compounds and methods for inhibiting IQGAP1.
Information query
Patent Agency Ranking
0/0